Global Immune Checkpoint Inhibitors Market Analysis Report 2024-2030: Growing FDA Approvals of Immune Checkpoint Inhibitors and Increasing Funding for Advancing Cancer Immunotherapy
24 juin 2024 10h26 HE
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Market Size, Share & Trends Analysis Report by Type (PD-1, PD-L1, CTLA-4), Application (Lung Cancer, Breast...
Global KRAS Inhibitors Market & Clinical Trials Future Market Outlook 2030: 2 Approved KRAS Inhibitors and 90+ Drugs KRAS Inhibitors in Clinical Trials
20 juin 2024 06h59 HE
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market & Clinical Trials Future Outlook 2030" report has been added to ResearchAndMarkets.com's offering. With the...
Oncolytic Virus Cancer Therapy Pipeline Analysis, 2024 - Showing Promise with Over 120 Companies and 125 Drugs in Development
14 juin 2024 06h51 HE
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The field of oncolytic virus...
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges
31 mai 2024 04h48 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's...
Immune Checkpoint Drugs in Oncology: Analytical Tool – A Must-Have Handbook for Business Developers, BI/CI Operatives, and Clinical Developers
25 avr. 2024 10h26 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Cancer cells sometimes find ways to...
PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2024: Clinical Assessment of Over 200 Drugs Being Developed by More than 180 Companies
01 mars 2024 08h58 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024" report has been added to ResearchAndMarkets.com's offering.This "PD-1 and PD-L1 Inhibitors -...
Global Next Generation Immunotherapies Market Forecast Report to 2028, by Drug Class, Route of Administration, Distribution Channel and Geography
01 févr. 2024 10h27 HE
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Next Generation Immunotherapies Market (2023-2028) by Drug Class, Route of Administration, Distribution Channel, and Geography, Competitive...
Immuno-Oncology Market Poised for Substantial Growth, Driven by Advanced Technologies and Biomarker Integration
31 janv. 2024 08h10 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Metastatic Cancer Drugs Market Size Set to Expand Globally
18 janv. 2024 21h23 HE
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The metastatic cancer drugs market is...
Global Cancer Therapeutics Market (2023-2028): Cancer Chemotherapy Dominates Market - A Closer Look at Therapeutic Types
07 sept. 2023 05h58 HE
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market (2023-2028) by Therapeutic Type, Drug Type, Application, End-User and Geography, Competitive Analysis, Impact of...